Is it time to bet on a turnaround?
Sam Bankman-Fried's ambition for celebrity endorsements might have snared the "Anti-Hero" singer, but she proved to be smarter than a lot of other famous people.
The latest decision from ExxonMobil won't win any popularity contest, but it will make it a champion to its investors. On Thursday, the oil giant...
Investors searching for that feeling telling you market sentiment is shifting to a more positive outlook have been brought down to earth again. Following 2022’s market behavior to a tee, the recent rally has run into a brick wall. To wit, the S&P 500 notched 5 consecutive negative sessions over the last week with investors mulling over the prospect of a recession. Indeed, financial experts have been sounding the warning bells on the precarious state of the global economy. One of the doomsayers h
Yahoo Finance Live's Seana Smith breaks down the stocks trending in the after-hours trading session.
At age 51, Anne Schieber was broke and disillusioned. She had worked for the IRS for 23 years and was regarded as one of the agency’s top auditors. But she never got promoted and never earned more than $3,150 in a year. With half her life already behind her, her retirement prospects looked bleak. But Schieber had learned a powerful secret from years of studying the tax returns of America’s richest residents. Over the next 50 years, it earned her a 449,000% return — making Schieber one of the mos
Tesla Inc will suspend Model Y assembly at its Shanghai plant between Dec. 25 and Jan. 1, according to an internal memo detailing the automaker's latest production plan, reviewed by Reuters, and two people with knowledge of the matter. The suspension of assembly at the end of the month would be part of a cut in planned production of about 30% in the month for the Model Y, Tesla's best-selling model, at the Shanghai factory, the two people said. The Shanghai factory, the most important manufacturing hub for Elon Musk's electric vehicle company, kept normal operations during the last week of December last year.
Have an issue with your financial adviser or looking to hire a new one? Email firstname.lastname@example.org.
Pharvaris NV (NASDAQ: PHVS) announced topline data from the RAPIDe-1 Phase 2 study, demonstrating statistically significant results of PHVS416 as an oral on-demand treatment for hereditary angioedema (HAE) attacks. The study's primary endpoint is the change of a three-symptom composite (skin pain, skin swelling, abdominal pain) visual analog scale (VAS-3) score from pre-treatment to four hours post-treatment. Topline data from 147 attacks collected by 62 patients show that dose levels of PHVS416
After falling for much of the week, the major stock market indexes were gaining ground early Thursday as investors digested the latest unemployment numbers. Last week's initial jobless claims suggest the Federal Reserve's campaign to combat inflation may finally be bearing fruit. Investors used that positive development as an excuse to buy up their favorite beaten-down tech stocks.
Retirement-eligible salaried employees at Ford were warned about retiring this year to maximize a lump sum pension payment.
Buy and hold forever? Not always.
In this article, we will discuss the 14 Best Marijuana Stocks To Buy Now. You can skip our detailed industry analysis and go directly to the 5 Best Marijuana Stocks To Buy Now. The cannabis industry is expected to undergo rapid changes in the coming years. One reason is the increasing awareness of the health benefits […]
In this article, we will discuss the 15 best electric car stocks to buy now. If you want to explore similar stocks, you can also take a look at 5 Best Electric Car Stocks To Buy Now. The Electric Car Industry: An Analysis Electric car stocks are increasingly becoming a popular investment option as the […]
ARK ETF Founder Cathie Wood joins Yahoo Finance Live for a wide-ranging interview on the state of the crypto market, Elon Musk, Fed policy, Teladoc, and more.
(Bloomberg) -- US equity futures rose Friday before a report on US producer prices that will be one of the final pieces of data to inform a rate decision by the Federal Reserve next week. Most Read from BloombergTesla's Troubles Are Piling Up While Elon Musk Is Distracted With TwitterPutin Calls Russian Nukes Deterrent Factor, Says War Risk RisingWNBA Star Griner Freed in One-for-One Swap for Arms DealerElon Musk’s Bankers Consider Tesla Margin Loans to Cut Risky Twitter DebtPeru’s President Acc
JJK Research Associates Janet Joseph Kloppenburg joins Yahoo Finance Live to discuss Lululemon's latest earnings report, the designer brand's operating margins and forward outlook, and the brand's pricing after the Black Friday shopping event.
Yahoo Finance's Jared Blikre highlights which stocks are making moves at the end of the trading session on Thursday.
(Bloomberg) -- While Elon Musk is busy overhauling newly acquired Twitter Inc., Tesla Inc. is facing increasingly urgent issues and testing the faith of some of its chief executive’s biggest fans.Most Read from BloombergTesla's Troubles Are Piling Up While Elon Musk Is Distracted With TwitterPutin Calls Russian Nukes Deterrent Factor, Says War Risk RisingWNBA Star Griner Freed in One-for-One Swap for Arms DealerElon Musk’s Bankers Consider Tesla Margin Loans to Cut Risky Twitter DebtPeru’s Presi